News Flash: Eurex clears our first USD IRS and also becomes the second largest OTC CCP in Europe.
The ESMA EMIR Q&A has been updated to version 8, the new or modified questions are listed below. They seem to be addressing 'long tail' issues and don't appear to create any new operational implementation details.
One of the questions which many in Europe would like to understand, is how ready (or not) firms are to participate in central clearing, especially now that ESMA are working through the regulatory process to begin mandatory clearing.
According to a Risk Magazine article (subscription required), medium-sized financial institutions are going to have a tough time moving from Value at Risk (VaR) to Expected Shortfall (ES) for the purposes of calculating trading-book capital requirements.
2014 will be an important year for cross-border rules as Europe becomes the next frontier in global regulation.
The only way cost is going for OTC products is up - and the result will see structural changes to the firms operating in the OTC market.
The Bank of England have published a study into the way IM models work when reacting to stressed market conditions, comparing models such as VaR, Historic Simular VaR and HSVaR with an Exponentially Weighted Moving Average (EWMA) filter.
The International Swaps and Derivatives Association, Inc.
There has been some confusion recently over Funding Value Adjustment (FVA).
Sapient Global Markets' annual Glossary of Financial Terms is one of the industry's most comprehensive guides to the latest terminology for capital and commodities markets.
I had to post this photo - it's the second Shield Bug I've got a good photo of - those of you who've received a business card from me may have seen the other, a green variety on an Echinacea.
LSE Group moving into Swap Futures?
CFTC unveiled its approach to removal of the package trade exemptive relief on the SEF MAT obligation. The short term focus is on MAT swap vs mandated cleared swap package and swap spreads vs US Treasuries.
Front-loading, the obigation to move trades into clearing retrospectively is a major problem for pricing OTC trades. ESMA has written a letter / proposal to the European Commission to try and defuse this unexpected consequence of EMIR.
A speech by Steven Maijoor, Chair, European Securities and Markets Authority comments on European Regulation and future challenges to market reform.
With cleared derivatives set to require between $0.5tn and $2.6tn of additional collateral, buy and sell side firms are increasingly looking for ways to lower their costs and monetise their collateral
Risk magazine sponsored by IBM conducted a global survey from 28 February until 27 March 20
- « first
- ‹ previous
- next ›
- last »